ISPC vs LHX · rev $307.9K vs P/E 34, rev $5.88B
iSpecimen Inc (ISPC) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported ISPC revenue for 2026-06-30 was $307.9K. Net income was -$3.6M. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. ISPC currently screens at market cap $4.4M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
ISPC currently screens at market cap $4.4M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the ISPC and LHX stock pages for the full models.
Not investment advice.